Latest filing published 21 Dec 2015 for Evofem Biosciences, Inc., €693.
Insider track record
No signal scores available.
Kenneth W. Locke: trading record in brief
Kenneth W. Locke discloses dealings in Evofem Biosciences, Inc. to SEC (Form 4). Over a trading history stretching from 18 November 2015 to 17 December 2015, the count stands at 3 filings.
No open-market purchase appears, only 2 sales worth €48k. Besides market trades, the filings include 1 option exercise.
Most recently, on 21 December 2015, the filings show an open-market sale worth €693 in Evofem Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kenneth W. Locke
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 598 shares@ US$1.26Common StockSEC:0001209191-15-086399:0
- 6,098 shares@ US$8.30Common StockSEC:0001209191-15-081396:0
2 of 2 declarations